TECH
Bio-TechnePrevious close
72.33
Change
−0.01 / −0.01%
52-Week Range
43.20 – 72.62
P/E (TTM)
62.3
Forward P/E
35.2
Based on consensus earnings for the next 12 months
Market Cap
$11.3B
1M
−0.08%
S&P 500 −2.41% over same period
Volume / Avg Volume
3.6M / 2.6M
1.41× average
Recent Earnings
Click to read the FinDog analysis| Period | Reported | Revenue | EPS Actual / Est. | Analysis |
|---|---|---|---|---|
| FY2026 Q4 Quarter ended 2026-06 | 2026-08-12 | $1.2B | 0.52 / 0.53 | Read analysis → |
| FY2026 Q3 Quarter ended 2026-03 | 2026-05-06 | $311M | 0.53 / 0.55 | Pending |
| FY2026 Q2 Quarter ended 2025-12 | 2026-02-04 | — | — / — | Pending |
| FY2026 Q1 Quarter ended 2025-09 | 2025-11-05 | — | — / — | Pending |
| FY2025 Q4 Quarter ended 2025-06 | 2025-08-06 | $1.2B | 0.53 / — | Pending |
| FY2025 Q3 Quarter ended 2025-03 | 2025-05-07 | — | — / — | Pending |
Decision Panel
Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market dataValuation
P/E is at percentile 42 of its 5-year rangeMid-range
5-year range 39.7 – 132.5 · Median 65.8
Last 4 quarters: $41.7M in buybacks + $49.9M in dividends, 0.81% of market cap combined
P/E (TTM)
62.3
P/B
5.4
P/S
9.3
Dividend Yield
0.50%
Earnings Reaction
Over the last 6 reports, the stock moved ±2.9% on average on the first trading day after, rising 3 times
Most recent −0.08%
Insider Trading
View all →Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
No open-market buys or sells by officers or directors in the last 90 days.
Multi-Quarter Financial Trends
View all quarters →Last 12 quarters · As reported by the company
| Quarter | Revenue ($B) | YoY | Gross Margin | Net Income ($B) | EPS |
|---|---|---|---|---|---|
| FY2026 Q4 | 0.32 | +1.3% | 65.8% | — | 0.36 |
| FY2026 Q3 | 0.31 | −1.5% | 66.9% | 0.05 | 0.32 |
| FY2026 Q2 | 0.30 | −0.4% | 64.6% | 0.04 | 0.24 |
| FY2026 Q1 | 0.29 | −1.0% | 65.6% | 0.04 | 0.24 |
| FY2025 Q4 | 0.32 | +3.5% | 62.7% | -0.02 | -0.11 |
| FY2025 Q3 | 0.32 | +4.2% | 67.9% | 0.02 | 0.14 |
| FY2025 Q2 | 0.30 | +9.0% | 65.3% | 0.03 | 0.22 |
| FY2025 Q1 | 0.29 | +4.5% | 63.2% | 0.03 | 0.21 |
| FY2024 Q4 | 0.31 | +1.6% | 66.4% | 0.04 | 0.26 |
| FY2024 Q3 | 0.30 | +3.2% | 67.4% | 0.05 | 0.31 |
| FY2024 Q2 | 0.27 | +0.4% | 64.8% | 0.03 | 0.17 |
| FY2024 Q1 | 0.28 | +2.7% | 66.9% | 0.05 | 0.31 |
| Ticker | P/E | Revenue YoY | Gross Margin | 1M | View |
|---|---|---|---|---|---|
| TECH | 62.3 | +1.3% | 65.8% | −0.08% | Neutral |
| LLY | 39.9 | +47.7% | 85.8% | −3.83% | Bullish |
| JNJ | 30.6 | +6.6% | 68.2% | +1.87% | Bullish |
| ABBV | 73.7 | +10.2% | 74.7% | +4.87% | Neutral |
| MRK | 112.2 | +5.1% | 73.5% | +6.57% | Neutral |
| UNH | 23.9 | +0.4% | 88.1% | −5.15% | Neutral |
| TMO | 34.4 | +10.5% | — | +10.75% | Bullish |
| AMGN | 23.3 | +9.5% | 72.0% | −10.26% | Neutral |
| GILD | — | +10.2% | 79.8% | +6.31% | Neutral |